GLP-1 drugs may be hailed as a medical breakthrough in obesity care, but Indian experts warn they are no cosmetic quick-fix. Top doctors cautioned that misuse of these powerful clinical tools — now increasingly accessible without prescriptions—could trigger a public health disaster. With no real-time pharmacovigilance system in place, India is “flying blind,” experts said. They urged that a regulatory oversight to prevent black-market sales and off-label misuse is a must.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/FbjUTSR
via gqrds
No comments:
Post a Comment